CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Chengda Pharmaceuticals Co., Ltd.

    Chengda Pharmaceuticals Co., Ltd.

    Verified
    CDMO
    China
    https://www.chengdapharm.com/eng/cdmobusiness/list.aspx?lcid=85
    Drug Substance
    Chemistry, Manufacturing and Controls
    Regulatory, Tech Transfer & Support Services
    Excipients & Specialty Ingredients
    Qualification/Validation Services
    Analytical & Bioanalytical Services
    Contract Research Organization
    Company Overview

    About

    Chengda Pharmaceutical positions itself as a CDMO partner with over two decades of experience, focusing on process development and industrialization for key pharmaceutical intermediates and APIs. Its core strengths lie in a combination of regulatory compliance, flexible production capabilities, and strategic expansion into high-growth therapeutic areas. Regulatory Compliance and Global Market Access Chengda has established a robust quality management system that integrates drug cGMP (ICH Q7) with ISO9001 and other standards, enabling it to meet the stringent requirements of multinational pharmaceutical companies. The company has successfully passed on-site inspections by regulatory agencies including the U.S. FDA, China's NMPA, Japan's PMDA, and Malaysia's NPRA. Its API registration applications have also passed technical reviews by authorities such as the FDA, EDQM, and Health Canada. This compliance infrastructure allows Chengda to embed its CDMO services directly into the innovation chains of its clients, supporting both clinical development and commercial manufacturing. Production Flexibility and End-to-End Service Capability The company offers a broad service range spanning from kilogram to ton-scale production of key intermediates and APIs, covering process R&D, optimization, analytical method development and validation, stability studies, and customized manufacturing. Its production facilities are designed for diverse chemical reactions, featuring capabilities for ultra-low temperature reactions (down to -78°C), high-pressure hydrogenation, anhydrous and oxygen-free synthesis, and chiral compound synthesis. With a total reaction volume of approximately 950,000 liters and multiple clean rooms, Chengda can accommodate different scales and technical requirements, from preclinical studies to commercial launch. Strategic Positioning in High-Growth Modalities Chengda has made strategic moves into two high-growth areas: small-molecule GLP-1 intermediates for weight management and oligonucleotide (small nucleic acid) intermediates. The company has progressed from laboratory development to commercial-scale readiness for GLP-1 intermediates and can supply high-quality monomers and delivery system intermediates for siRNA and ASO drugs. This expansion leverages its existing expertise in complex chemical synthesis and positions the company to capture demand in these rapidly expanding therapeutic categories. Proven Track Record with Global Clients Chengda's client base includes multinational pharmaceutical companies such as Incyte, Helsinn, Eli Lilly/Evonik, Gilead, and GSK. Its ability to maintain long-term relationships and expand the scope of collaboration reflects a consistent delivery record and growing client trust in its technical and manufacturing capabilities

    Therapeutic Areas

    Oncology
    Cardiovascular
    Infectious Disease
    Quick Facts
    HQ:China
    Capabilities & Services

    Core Capabilities

    • Small Molecule API
    • Small Molecule Drug Product
    • Stability Studies

    Containment Capabilities

    None Required

    Production Scales

    R&D / Pre-clinical
    Phase I Clinical Trials
    Phase II Clinical Trials
    Phase III Clinical Trials
    Pilot Scale
    Commercial Scale
    Large Scale (Metric Ton+)

    Annual Capacity

    Commercial (10,000-100,000 units/year)

    Markets Served

    North America
    Europe
    Asia Pacific
    Latin America
    Middle East
    Africa
    Manufacturing Facilities

    1 site worldwide

    Jiaxing, China

    No.36, Huanghe Road, Huimin Subdistrict, Jiashan, Jiaxing, Zhejiang,, 314100,
    View on Map
    Certifications

    GMP (Good Manufacturing Practice)

    Various National Authorities

    FDA (U.S. Food & Drug Administration)

    Various

    EMA (European Medicines Agency)

    Various

    ISO 9001 (Quality Management)

    Various

    ISO 14001 (Environmental Management)

    International Organization for Standardization

    ICH (International Council for Harmonisation)

    International Council for Harmonisation

    PMDA (Japan Pharmaceuticals and Medical Devices Agency)

    Pharmaceuticals and Medical Devices Agency

    Health Canada

    Various
    Send Inquiry

    Please log in to contact this provider.

    Key facts about Chengda Pharmaceuticals Co., Ltd.

    • Chengda Pharmaceuticals Co., Ltd. is headquartered in China.
    • Chengda Pharmaceuticals Co., Ltd. has one manufacturing site listed on CDMO Hub, in Jiaxing, China.
    • Chengda Pharmaceuticals Co., Ltd.'s capabilities include Small Molecule API, Small Molecule Drug Product and Stability Studies.

    Find CDMOs like Chengda Pharmaceuticals Co., Ltd.

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in ChinaCDMOs in AsiaSmall Molecule API CDMOsSmall Molecule Drug Product CDMOsStability Studies CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA